Add the specialty areas of your choice to tailor to your professional interests.
Save & Create free account
No thanks, just apply selection
I already have an account. Login

User login

We offer our registered users tailored information, free online courses and exclusive content.

Can't find your password?
Reset it here.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

7th EMEA Forum on cardiovascular risks

7th EMEA Forum on cardiovascular risks
  • Cardiometabolic
  • Hypertension
International workshop
Saturday, Nov 24 2018
Amsterdam, Netherlands



Event format

Learning Journey



Registration status
Not applicable

To register for this event, contact

For registration and accomodation please
Meridiano Congress International
Event Manager: Claudia Maddalena
T +39 06 88595 232 - F +39 06 88595 234

Registration fee


Target audiences

This programme is designed for cardiologists and internists involved in preventing and managing patients with cardiovascular risk factors or who are experiencing cardiovascular diseases.



It is well established that high blood pressure is the most important cardiovascular risk factor and the leading cause of death worldwide. In the near future the prevalence of hypertension will increase worldwide despite  the  global  effort  to  combat  this  important  disease.  Recent American and European Guidelines for hypertension have stimulated discussion  about on defining more ambitious targets for antihypertensive treatment, thereby supporting the need for more aggressive treatment. On the other hand, it is necessary to examine whether study results supporting the new targets, including the SPRINT trial, are truly applicable in clinical practice. Another new aspect raised by Guidelines is the primary role of fixed-dose combination therapy. It is  therefore  necessary  to  examine  all  the  different  available combinations to understand their differences and specific indications. EXCEMED has designed a comprehensive Blended Learning Journey to increase knowledge in cardiovascular disease with a specific focus on hypertension.  This programme  will  address  the  most  recent advancements of research in the area of this cardiovascular risk factor and will discuss the best approach for clinical management of the complex hypertensive patient in daily practice. A multistep approach will be used, encompassing web-based and live activities. All activities – in-person and online – will involve the full interaction of learners.

Learning objectives

• Discuss the most recent indications from American and European Guidelines concerning the blood pressure values which should be considered to start  ntihypertensive treatment and the blood pressure targets for therapy in patients with complicated and non complicated hypertension.

• Personalize antihypertensive treatment by presenting the more recent novelties in the combination therapy, including the fixed-dose based strategy and the indications to prescribe a combination of a beta-blocker with a calcium antagonist.

• Optimize the use of beta-blockers in patients with different cardiovascular complications including diabetes, coronary artery disease and heart failure.

Accreditation details

The event “7 th EMEA forum on cardiovascular risks” is accredited by the European Board for Accreditation in Cardiology (EBAC ® ) for 5 (five) hours of External CME credits.
Each participant should claim only those hours of credit that have actually been spent in the educational  activity.  EBAC ® works  according  to  the  quality  standards  of  the  European
Accreditation Council for Continuing Medical Education (EACCME ® ), which is an institution of the European Union of Medical Specialists (UEMS).

Scientific programme

Welcome and introduction
Giuseppe Mancia (Italy)


Session I


08.30 Slide kit | Video
L1  Blood pressure targets in Hypertensive patients: European Guidelines
Giuseppe Mancia (Italy)

08.50 Slide kit | Video
L2 Should increased heart rate be treated in hypertension?
Harry A.J. Struijker-Boudier (The Netherlands)

09.10 Slide kit | Video
L3 New possibilities for the fixed-dose combination treatment in hypertension
Leonidas Poulimenos (Greece)

Panel discussion

Coffee break


Session II


10.10 Slide kit | Video
L4 Best practice in the management of stable chronic angina
Leonidas Poulimenos (Greece)

10.30 Slide kit | Video
L5 From hypertension via the heart and arteries to heart failure: prevention strategies
Kennedy Cruickshank (UK)

10.50 Slide kit | Video
L6 Use of betablockers in diabetes
Brian Tomlinson (Hong Kong)

Panel discussion


Session III


Working groups

This session includes two different parallel workshops, each lasting 1 hour. Participants will be divided into groups and will attend both workshops in rotation. By the end of the session each participant will have attended both workshops.

WG1 Slide kit
Complex patient with hypertension: when we need a beta-blocker
Presenter: Harry A.J. Struijker-Boudier (The Netherlands)

WG2 Slide kit
How to optimize treatment in patients with heart failure
Presenter: Brian Tomlinson (Hong Kong)

Take home messages from the working groups and wrap up

Closing remarks
Giuseppe Mancia (Italy)

End of the workshop

Closing lunch



Giuseppe Mancia

Department of Clinical Medicine
University of Milano-Bicocca
Milan, Italy

Kennedy Cruickshank

Professor of Cardiovascular Medicine & Diabetes
Diabetes and Nutritional Sciences Division
King’s College London
London, United Kingdom
Consultant physician
St Thomas’ & Guy’s Hospitals
London, United Kingdom

Brian Tomlinson

Specialist in Internal Medicine & Clinical Pharmacology
Department of Medicine and Therapeutics
Adjunct Professor
The Chinese University of Hong Kong
Hong Kong, China

Giuseppe Mancia

Department of Clinical Medicine
University of Milano-Bicocca
Milan, Italy
Slide kit
Leonidas Poulimenos
Harry Struijker-Boudier
Slide kit
Harry Struijker-Boudier
Slide kit
Harry Struijker-Boudier
Slide kit
Brian Tomlinson
Slide kit
Brian Tomlinson
Brian Tomlinson